Literature DB >> 14631504

Molecular typing of N. gonorrhoeae strains prevalent in the Russian Federation.

E N Il'ina1, M V Malakhova, V A Vereshchagin, V M Govorun, V I Sergienko, M M Zubkov, M M Vasil'ev, A A Kubanova.   

Abstract

Genetic polymorphism of Russian population of N. gonorrhoeae was detected and a system for genotyping of its clinical strains was introduced into practice. Comparative analysis of the prevalence of N. gonorrhoeae genotypes in Russia and abroad was carried out. For adaptation of the methods of molecular typing of N. gonorrhoeae strains and its approbation on clinical strains isolated in Russia 41 clinical strains of N. gonorrhoeae were typed. The predominance of PIB serovar (83%) was demonstrated.

Entities:  

Mesh：

Year:  2003        PMID： 14631504     DOI： 10.1023/a:1026379209810

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN： 0007-4888            Impact factor:   0.804


  3 in total

1.  Direct bacterial profiling by matrix-assisted laser desorption-ionization time-of-flight mass spectrometry for identification of pathogenic Neisseria.

Authors:  Elena N Ilina; Alexandra D Borovskaya; Maja M Malakhova; Vladimir A Vereshchagin; Anna A Kubanova; Alexander N Kruglov; Tatyana S Svistunova; Anaida O Gazarian; Thomas Maier; Markus Kostrzewa; Vadim M Govorun
Journal:  J Mol Diagn       Date:  2008-12-18       Impact factor: 5.568

2.  Predominant porB1A and porB1B genotypes and correlation of gene mutations with drug resistance in Neisseria gonorrhoeae isolates in Eastern China.

Authors:  Aihua Sun; Xingli Fan; Ye Gu; Peng Du; Renxian Tang; Yafei Mao; Xuai Lin; Jie Yan
Journal:  BMC Infect Dis       Date:  2010-11-10       Impact factor: 3.090

3.  Relation between genetic markers of drug resistance and susceptibility profile of clinical Neisseria gonorrhoeae strains.

Authors:  Elena N Ilina; Vladimir A Vereshchagin; Alexandra D Borovskaya; Maja V Malakhova; Sergei V Sidorenko; Nazar C Al-Khafaji; Anna A Kubanova; Vadim M Govorun
Journal:  Antimicrob Agents Chemother       Date:  2008-03-31       Impact factor: 5.191
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.